Pharmaceuticals

Cardiac Biomarkers Testing Market Size Forecast: Revenue and CAGR by 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Cardiac Biomarkers Testing Industry In 2025?

The cardiac biomarkers testing market size has experienced rapid growth over recent years. It is projected to expand from $13.48 billion in 2024 to $14.95 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.9%. The expansion observed in prior periods is attributable to the increasing incidence of cardiovascular diseases, an aging global population, various awareness and education initiatives, government initiatives and healthcare policies, and a rise in healthcare expenditure.

The market for cardiac biomarkers testing is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $23.24 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.7%. Factors contributing to this growth during the projected timeframe include personalized medicine, an increasing worldwide prevalence of cardiovascular diseases, the incorporation of artificial intelligence (AI) into diagnostic processes, the spread of point-of-care testing, and a heightened focus on detecting diseases early. Significant trends anticipated for this period encompass technological progress, improvements in AI-assisted diagnostics, the expansion of point-of-care testing (POCT), enhanced multiplexing capabilities, and the identification and confirmation of new biomarkers.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9436&type=smp

What Are The Top Growth Drivers Impacting The Cardiac Biomarkers Testing Market Outlook?

The future expansion of the cardiac biomarkers testing market is anticipated to be driven by the rising incidence of cardiovascular diseases. These conditions encompass ailments impacting the heart or blood vessels. Cardiac biomarker tests assist in assessing biomarker levels quickly to gauge the severity and extent of a heart attack. Consequently, a rise in cardiovascular disease cases will escalate the need for cardiac biomarker testing solutions. For instance, the American College of Cardiology, a US-based professional medical organization, reported in August 2022 that cardiovascular risk factors and disease rates are projected to substantially increase in the United States by 2060. This underscores how the growing prevalence of cardiovascular diseases is propelling the growth of the cardiac biomarkers testing market.

What Are The Key Segments In The Cardiac Biomarkers Testing Market?

The cardiac biomarkers testing market covered in this report is segmented –

1) By Biomarkers Type: Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarkers Types

2) By Application: Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications

3) By End-User: Hospitals, Specialty Clinics

Subsegments:

1) By Creatine Kinase (CK-MB): Total CK-MB, CK-MB Mass

2) By Troponins: Cardiac Troponin I (cTnI), Cardiac Troponin T (cTnT)

3) By Myoglobin: Total Myoglobin

4) By Natriuretic Peptides: B-Type Natriuretic Peptide (BNP), N-Terminal Pro B-Type Natriuretic Peptide (NT-ProBNP)

5) By Ischemia Modified Albumin (IMA): IMA Levels

6) By Other Biomarkers Types: C-Reactive Protein (CRP), Heart-Type Fatty Acid-Binding Protein (H-FABP), Soluble ST2

Which Market Trends Are Creating New Opportunities In The Cardiac Biomarkers Testing Industry?

Major companies engaged in the cardiac biomarker testing market are establishing strategic partnerships to provide technology for detecting early warning signs of heart conditions and improving patient outcomes. These strategic alliances in cardiac biomarker testing encourage cooperation between companies, facilitating the development of innovative diagnostics, expanding their market reach, and accelerating the availability of advanced testing solutions for enhanced cardiovascular care. For instance, in September 2024, MediBuddy, an Indian-based healthcare technology company that offers a comprehensive platform for telehealth services, health management, and insurance assistance, formed a partnership with Philips, a Netherlands-based conglomerate corporation. Through this collaboration, they aim to improve cardiac care in India by incorporating Philips’ HeartPrint technology, which allows for regular monitoring and risk assessment of heart health. This forward-thinking approach provides users with advanced tools on the MediBuddy platform, thereby promoting proactive management of heart health and better outcomes.

Who Are The Core Companies Influencing The Cardiac Biomarkers Testing Market Landscape?

Major companies operating in the cardiac biomarkers testing market include Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Biomérieux SA, Becton Dickinson and Company, Randox Laboratories Ltd., Enzo Biochem Inc., Creative Diagnostics Inc., Merck Co. & KGaA, Beckman Coulter Inc., QIAGEN N.V., PerkinElmer Inc., Tosoh Corporation, Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., DIALAB GmbH, CardioGenics Holdings Inc., Lepu Medical Technology (Beijing) Co. Ltd., Biosynex SA, Charles River Laboratories, Quidel Corporation, Life Diagnostics, Trinity Biotech plc, Guangzhou Wondfo Biotech Co. Ltd., Nova Biomedical Corp., Ortho Clinical Diagnostics Inc., Sekisui Diagnostics Inc., Abcam plc, Bio-Techne Corporation

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

How Is Cardiac Biomarkers Testing Market Demand Varying Across Different Regions?

North America was the largest region in the cardiac biomarkers testing market in 2024. The regions covered in the cardiac biomarkers testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Cardiac Biomarkers Testing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9436&type=smp

Browse Through More Reports Similar to the Global Cardiac Biomarkers Testing Market 2025, By The Business Research Company

Cardiovascular Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Cardiac Assist Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Cardiac Rhythm Management Crm Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-rhythm-management-crm-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795